You are here: Home » Markets » News
Business Standard

Sun Pharma slides 4% on report of Sebi ordering forensic audit

The audit has been ordered based on allegations of corporate governance and tax-related offences and securities market-related violations by the company

Topics
Buzzing stocks | Sun Pharma

SI Reporter  |  New Delhi 

Sun Pharma

Sun Pharmaceutical Industries dipped 5 per cent to Rs 416.85 apiece in Wednesday's trade on the BSE after reports suggested that Securities and Exchange Board of India (Sebi) has ordered a forensic audit against the company to look into allegations of financial irregularities and lapses in corporate governance standards.

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.

SUBSCRIBE TO INSIGHTS

What you get on Business Standard Premium?

  • icon Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • icon Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • icon Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
  • icon Pick your 5 favourite companies, get a daily email with all news updates on them.
  • icon 26 years of website archives.
  • icon Preferential invites to Business Standard events.

OR


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Wed, September 04 2019. 09:59 IST
RECOMMENDED FOR YOU
.